Gad A. Getz
Broad Institute
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Immune Cell Function and Interaction
Strong evidence · 1 supporting paper · latest 2026
Cancer Genomics and Diagnostics
Strong evidence · 1 supporting paper · latest 2026
Immune cells in cancer
Solid evidence · 3 supporting papers · latest 2026
Cancer Immunotherapy and Biomarkers
Solid evidence · 2 supporting papers · latest 2026
Lymphoma Diagnosis and Treatment
Solid evidence · 2 supporting papers · latest 2026
Glioma Diagnosis and Treatment
Solid evidence · 2 supporting papers · latest 2026
Genetic factors in colorectal cancer
Solid evidence · 1 supporting paper · latest 2026
CAR-T cell therapy research
Supporting evidence · 1 supporting paper · latest 2026
Publications (16)
Differential T cell clonal dynamics underlie outcomes to frontline chemoimmunotherapy in advanced gastric cancer
2026DOIPMID 40909828
Actionable genetic landscape and dynamics in circulating DNA from 12,827 patients with metastatic breast cancer
2026DOI
Follicular Lymphoma Transformation is Characterized by Cytokine-associated Remodeling of Stromal and Macrophage Compartments
2026DOIPMID 42550967
Proteogenomic analysis of pediatric and AYA high-grade glioma reveals age-dependent biology, female-male differences, and kinase targets
2026DOIPMID 42753723
Macrophage reprogramming, not CD8 T cell dynamics, characterizes durable disease control following PD-1 blockade in smoldering myeloma
2026DOIPMID 42693161
ID #544 Patterns of hypermutation shape tumorigenesis and immunotherapy response in mismatch-repair-deficient glioma
2026DOI
Abstract PR001: Cytokine-linked stromal remodeling in transformed follicular lymphoma impacts macrophage function and can be detected non-invasively
2026DOI
Suppl. Table 6 from Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA Mutations
2026DOI
Suppl. Table 9 from Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA Mutations
2026DOI
Suppl. Table 5 from Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA Mutations
2026DOI
Suppl. Table 2 from Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA Mutations
2026DOI
Suppl. Table 10 from Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA Mutations
2026DOI
Suppl. Table 4 from Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA Mutations
2026DOI
Suppl. Table 1 from Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA Mutations
2026DOI
Suppl. Table 3 from Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA Mutations
2026DOI
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Broad Institute
Source: OpenAlex · retrieved 2026-09-29
Source: ScienceWe Extractor · retrieved 2026-09-27